Production (Stage)
KP Tissue Inc.
KPTSF
$6.56
$0.030.46%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | -- | -- |
| Operating Income | -- | -- | -- | -- | -- |
| Income Before Tax | 2.25M | 1.87M | 4.84M | 4.63M | 5.25M |
| Income Tax Expenses | 40.00K | 40.00K | 158.00K | 158.00K | 158.00K |
| Earnings from Continuing Operations | 2.21 | 1.83 | 4.68 | 4.47 | 5.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.21M | 1.83M | 4.68M | 4.47M | 5.10M |
| EBIT | -- | -- | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.22 | 0.18 | 0.47 | 0.45 | 0.51 |
| Normalized Basic EPS | 0.09 | 0.06 | 0.24 | 0.22 | 0.25 |
| EPS Diluted | 0.22 | 0.18 | 0.47 | 0.45 | 0.51 |
| Normalized Diluted EPS | 0.09 | 0.06 | 0.24 | 0.22 | 0.25 |
| Average Basic Shares Outstanding | 39.93M | 39.91M | 39.88M | 39.86M | 39.84M |
| Average Diluted Shares Outstanding | 39.93M | 39.91M | 39.88M | 39.86M | 39.84M |
| Dividend Per Share | 0.52 | 0.53 | 0.53 | 0.53 | 0.53 |
| Payout Ratio | 226.94% | 278.53% | 109.58% | 115.26% | 101.79% |